Regarding the readiness of the life sciences sector to successfully use generative AI in terms of infrastructure, regulatory considerations, and...
Read moreGlobal Biopharma Market Forecasts $566B By 2032 opposing Challenges With a compound annual growth rate of almost 8%, from $263...
Read moreDrug development which happens to be powered by AI, is going ahead and countering incentives from the Inflation Reduction Act...
Read moreLINDIS Biotech has received an EMA Marketing Authorization for catumaxomab, making it the only drug approved for the specific and...
Read moreAnthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathway Abelacimab...
Read moreBio-Rad Laboratories to Acquire Stilla Technologies to Expand Digital PCR Portfolio Stilla Technologies to Be Acquired by Bio-Rad Laboratories to...
Read moreDetermining the value of a medicine may be a challenging task. To put it another way, how much is the...
Read moreArtificial Intelligence (AI) is transforming the pharmaceutical industry, driving significant advancements across various stages of drug discovery, development, and production....
Read moreLonza is revolutionizing drug development with its AI-driven route scouting technology, allowing pharmaceutical companies to fast-track their investigational new drug...
Read moreDespite their track record of demonstrating significant therapeutic efficacy, biologics still face daunting challenges in their drug delivery. Biologics such...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.